West Pharmaceutical Servs WST is preparing to release its quarterly earnings on Thursday, 2024-10-24. Here's a brief overview of what investors should keep in mind before the announcement.
Analysts expect West Pharmaceutical Servs to report an earnings per share (EPS) of $1.50.
Investors in West Pharmaceutical Servs are eagerly awaiting the company's announcement, hoping for news of surpassing estimates and positive guidance for the next quarter.
It's worth noting for new investors that stock prices can be heavily influenced by future projections rather than just past performance.
Past Earnings Performance
Last quarter the company missed EPS by $0.22, which was followed by a 2.74% increase in the share price the next day.
Here's a look at West Pharmaceutical Servs's past performance and the resulting price change:
Quarter | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 |
---|---|---|---|---|
EPS Estimate | 1.74 | 1.26 | 1.78 | 1.86 |
EPS Actual | 1.52 | 1.56 | 1.83 | 2.16 |
Price Change % | 3.0% | -2.0% | 3.0% | -2.0% |
Performance of West Pharmaceutical Servs Shares
Shares of West Pharmaceutical Servs were trading at $286.4 as of October 22. Over the last 52-week period, shares are down 12.26%. Given that these returns are generally negative, long-term shareholders are likely bearish going into this earnings release.
This article was generated by Benzinga's automated content engine and reviewed by an editor.
© 2024 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
Trade confidently with insights and alerts from analyst ratings, free reports and breaking news that affects the stocks you care about.